Development and In-vitro characterization of floating drug delivery system of ketoconazole

  • Jagdish Rathi NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India
  • Mithun Bhowmick NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India
  • Rahul Sharma NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India
  • Sagar Panse NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India
  • Rupal Pandit NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India
  • Sachin Gupta NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Abstract

The oral route is increasingly being used for the delivery of therapeutic agents because the low cost of the therapy and ease of administration lead to high level of patient compliances.  Floating drug delivery system (FDDS) float in the gastric fluid and prolong GRT to obtain sufficient drug bioavailability, because of their lower bulk density compared to that of the aqueous medium. The aim of the present study is to prepare floating tablets as a delivery system for controlled release of Ketoconazole. Ketoconazole is a drug of choice in antifungal category and gives significant result. Floating tablets containing Ketoconazole were prepared by direct compression technique using varying concentrations of different grades of polymers of Hydrxy Propyl Cellulose & Xanthan gum. To evaluate the prepared floating tablets for various parameters like hardness, friability, uniformity of drug content, in-vitro floating studies, in-vitro dissolution studies.


Keywords: Ketoconazole, Floating drug delivery system, Hydrxy Propyl Cellulose, Xanthan gum

Downloads

Download data is not yet available.

Author Biographies

Jagdish Rathi, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Mithun Bhowmick, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Rahul Sharma, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Sagar Panse, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Rupal Pandit, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

Sachin Gupta, NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

NRI Institute of Pharmaceutical Sciences, bhopal (M.P), India

References

1. Arora S, Ali A, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS PharmSciTech 2005; 6(3):E372-E390.
2. Bardonnet, P.L., Faivre, V., Pugh, W.J., Piffaretti, J.C., Falson, F., Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J. Controlled Release 2006; 111:1–18.
3. Chien YW. Oral drug delivery and delivery system in novel drug delivery Systems, ed, 50, Marcel Dekker publication, New York, 1992.
4. Chien YW. Rate‐control drug delivery systems: controlled release vs. sustained release. Med Prog Techn 1989; 15:21-46.
5. Davis SS, Stockwell AF, Taylor MJ. The effect of density on the gastric emptying of single‐ and multiple‐ unit dosage forms, Pharm Res 1986; 3:208-213.
6. Gergogiannis YS, Rekkas DM, Dallos PP, Chailis NH. Floating and swelling characteristics of various excipients used in controlled release technology. Drug Dev Ind Pharm 1993; 19:1061-1081.
7. http://www.pharmainfo.net/exlusive/reviews/gastroretentive drugs a novel approach towards floating therapy/, 2007
8. Indian pharmacopoeia, Vol. II, 2007, pp -486
9. Chander S, Shireesh K, Nagendra B. Preparation and evaluation of gastro retentive floating tablets of ketoconazole. International Journal of Pharma Research and Development. 2010; 2(9):175–176.
10. Pare, A.; Yadav, S.K.; Patil, U.K. Formulation and evaluation of effervescent floating tablet of amlodipine besylate. Research J. Pharm. and Tech., 2008; 1(4).
11. Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. Effect of HPMC and Carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int J Pharm 2003; 253:13-22.
12. Acharya, S., Patra, S., Pani, N.R., Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design. Carbohydr. Polym. 2014; 102:360–368.
13. Mahesh C, Paras J, Sachin C, Rajesh S, Pradeep V. Development of sustained release gastro-retentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int J Pharm 2005; 304:178-84.
14. Pramod P, Someshwara RB, Suresh VK, Basavaraj CS, Anand A. Formulation and in vitro evaluation of floating matrix tablets of ofloxacin. Asian J Res Pharm Sci 2011; 1:17-22.
15. K. Mahalingan, S.Rajarajan, Bany Baby ,N.Sree Harsha, Formulation and Evaluation of Clarithromycin Extended Release Tablets, J. Pharm. Sci. & Res. 2009; 1(3):97-100.
16. Lagnajit Mahapatra , Gali Vidyasagar, Formulation and in vitro Evaluation of Gastroretentive Floating Tablets of Macrolide Antibiotic Based on Effervescent Technology using Clarithromycin as a Model Drug, Scientific Journal Impact Factor 2013; 5:105.
Statistics
70 Views | 53 Downloads
How to Cite
Rathi, J., Bhowmick, M., Sharma, R., Panse, S., Pandit, R., & Gupta, S. (2019). Development and In-vitro characterization of floating drug delivery system of ketoconazole. Journal of Drug Delivery and Therapeutics, 9(1), 22-29. https://doi.org/10.22270/jddt.v9i1.2153